Literature DB >> 23282773

[Psychometric properties and diagnostic usefulness of the Addenbrooke's Cognitive Examination-Revised in a Chilean elderly sample].

Carlos Muñoz-Neira1, Fernando Henríquez Ch, Josefina Ihnen J, Mauricio Sánchez C, Patricia Flores M, Andrea Slachevsky Ch.   

Abstract

BACKGROUND: The Addenbrooke's Cognitive Examination - Revised (ACE-R) is a good alternative to the Mini Mental State Examination (MMSE) for assessing cognitive capacities in dementia. AIM: To estimate the psychometric properties and diagnostic utility of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in a Chilean elderly sample.
MATERIAL AND METHODS: ACE-R was adapted for the Chilean population (ACE-R-Ch) and then administered to 60 dementia patients, 22 mild cognitive impairment (MCI) patients and 45 control subjects in addition to the MMSE for assessing global cognitive efficiency. Caregivers of dementia patients and collateral sources of MCI patients and elderly subjects without dementia were interviewed with measures of dementia severity, functional status in activities of daily living and cognitive changes. Convergent validity, internal consistency reliability, cutoff points, sensitivity and specificity for ACE-R-Ch were estimated.
RESULTS: Regarding convergent validity, the ACE-R-Ch showed significant correlations (p < 0,001) with another cognitive measure (r = 0,952 with MMSE), a rating for dementia severity (Spearman rho=-0,822 with CDR), functional capacity assessments (r = -0,70 with ADLQ-Ch; r = -0,725 with PFAQ-Ch; and r = 0,650 with IADL Scale) and a measure of cognitive changes (r = -0,633 with AD8-Ch). In terms of reliability, the test had a Cronbach alpha coefficient of 0.918. The best cut-off point to distinguish cases of dementia from control subjects was a score of 76, which reached a sensitivity of 0.92 and a specificity of 0.93.
CONCLUSIONS: The ACE-R-Ch showed acceptable psychometric properties, becoming a valid and reliable instrument to assess global cognitive efficiency or cognitive impairment. Its diagnostic utility to detect dementia patients also worked very well in a Chilean elderly sample.

Entities:  

Mesh:

Year:  2012        PMID: 23282773     DOI: 10.4067/S0034-98872012000800006

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  8 in total

1.  Cohort Profile: The Maule Cohort (MAUCO).

Authors:  Catterina Ferreccio; Andrea Huidobro; Sandra Cortés; Claudia Bambs; Pablo Toro; Vanessa Van De Wyngard; Johanna Acevedo; Fabio Paredes; Pía Venegas; Hugo Verdejo; Ximena Oyarzún-González; Paz Cook; Pablo F Castro; Claudia Foerster; Claudio Vargas; Jill Koshiol; Juan Carlos Araya; Francisco Cruz; Alejandro H Corvalán; Andrew F Quest; Marcelo J Kogan; Sergio Lavandero
Journal:  Int J Epidemiol       Date:  2020-06-01       Impact factor: 7.196

2.  Mapping the neuroanatomy of functional decline in Alzheimer's disease from basic to advanced activities of daily living.

Authors:  Andrea Slachevsky; Gonzalo Forno; Paulo Barraza; Eneida Mioshi; Carolina Delgado; Patricia Lillo; Fernando Henriquez; Eduardo Bravo; Mauricio Farias; Carlos Muñoz-Neira; Agustin Ibañez; Mario A Parra; Michael Hornberger
Journal:  J Neurol       Date:  2019-04-04       Impact factor: 4.849

3.  Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.

Authors:  Carlos Calderón; Christian Beyle; Oscar Véliz-García; Juan Bekios-Calfa
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

4.  Brief cognitive tests validated in Peru for detection of cognitive impairment A systematic mapping of the scientific literature.

Authors:  Nilton Custodio; Eder Herrera-Pérez; Rosa Montesinos; David Lira; Tatiana Metcalf
Journal:  Dement Neuropsychol       Date:  2020 Apr-Jun

Review 5.  Multidimensional Clinical Assessment in Frontotemporal Dementia and Its Spectrum in Latin America and the Caribbean: A Narrative Review and a Glance at Future Challenges.

Authors:  Fernando Henríquez; Victoria Cabello; Sandra Baez; Leonardo Cruz de Souza; Patricia Lillo; David Martínez-Pernía; Loreto Olavarría; Teresa Torralva; Andrea Slachevsky
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

6.  Chilean version of the INECO Frontal Screening (IFS-Ch): psychometric properties and diagnostic accuracy.

Authors:  Josefina Ihnen Jory; Andrés Antivilo Bruna; Carlos Muñoz-Neira; Andrea Slachevsky Chonchol
Journal:  Dement Neuropsychol       Date:  2013 Jan-Mar

7.  Reporting of the translation and cultural adaptation procedures of the Addenbrooke's Cognitive Examination version III (ACE-III) and its predecessors: a systematic review.

Authors:  Nadine Mirza; Maria Panagioti; Muhammad Wali Waheed; Waquas Waheed
Journal:  BMC Med Res Methodol       Date:  2017-09-13       Impact factor: 4.615

8.  Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile.

Authors:  Gada Musa; Fernando Henríquez; Carlos Muñoz-Neira; Carolina Delgado; Patricia Lillo; Andrea Slachevsky
Journal:  Dement Neuropsychol       Date:  2017 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.